Healthcare

You Built Something That Improves People’s Health. We Make Sure It Scales.

The specialized division of QC Growth, pairing a proven go-to-market sales model with deep healthcare and software business expertise, purpose-built for Seed-to-Series A founders ready to accelerate commercialization.

Book Time

Who is this for

Built for Seed to Series A B2B Healthcare companies

Who you work with

We specialize in go-to-market support for tech-enabled healthcare services looking to reach that next stage of growth. Whether you are selling to Providers, Payers, Pharma, or still determining your core ICP, we accelerate your market signal while scaling pipeline.

Who this isn’t for

Companies prioritizing regulatory approval before being commercial-ready.

Too early for a full engagement? Start with The GTM Co-Founder, our free, open-source GTM skills for founders doing it alone.

The problem

Legacy systems, buying committees, and rigorous compliance create complex sales

Healthcare commercialization is not like any other market. Long sales cycles, complex stakeholder maps, reimbursement hurdles, and compliance guardrails require deep domain expertise, not a generalist agency.

First way it goes wrong

First to the Table

In a market this crowded, the team that gets in the room first sets the requirements everyone else has to match. Waiting for a polished product means pitching into a decision that’s already been made.

Second way it goes wrong

The Window Closes

Buyers commit early and rarely revisit. Once they’ve chosen who they trust to solve this problem, reopening that conversation gets harder every month you wait.

Third way it goes wrong

Waiting for Ready

Founders hold off on commercial motion until the product feels finished. By then the buying committee has already chosen who they trust.

What we do

Strategy

Find the words

Positioning, ICP, and the story that lands with each unique decision maker and champion within the buying committee.

Execution

Find the buyers

Highly targeted, multi-channel campaign execution, reaching decision makers and champions at scale. Automating personalized sequences and SDR-level management to generate qualified meetings with core ICP.

GTM engineering

Build the machine

The stack that turns product usage into pipeline: intent signals, attribution, CRM, and automation wired to your own data.

Operations

Make it repeatable

The RevOps and process that make it repeatable: forecasting your board can trust, CRM data that holds up to scrutiny, and playbooks a new rep can run on day one

Solution

Why QC

An embedded team of seasoned healthcare operators and GTM experts

01

Led by Kori Bivens, a former RVO Health VP with 10+ years running HealthTech and Digital Health businesses

02

On the cutting edge of GTM technologies to identify and speak to high-value prospects

03

Full-stack for healthcare. Strategy, execution and tooling from one team that already knows how provider, payer and pharma buying committees decide.

The team

Who You'll be Working With

Kori Bivens

Kori Bivens

A healthcare GTM leader, bringing over a decade of experience driving growth for digital health companies. Kori spent the past 10+ years at Red Ventures and RVO Health, where her journey in health began after the company acquired Healthline.com, one of the leading consumer health media properties in the country.

Read more

Proof

Bluevia Health

Secured 15 buyer-level meetings in 90 days for Bluevia Health, without an existing hospital network to draw on.

Steadywell

Built a pre-seed advisory council of C-suite hospital executives from a standing start for Steadywell.

Hemaptics

Unlocked outbound pipeline for Hemaptics through internal doctors’ networks and clinical credibility, not cold outreach.

What you get

CRM Architecture & Hygiene

We rebuild your CRM’s object model, pipeline stages, and lead routing so every rep works from the same source of truth.

Signal-Driven Prospecting Setup

Intent and technographic tracking built in Clay, AI Ark, or your existing stack, tuned to your buyer’s real behavior.

Reporting & Pipeline Dashboards

Live dashboards that turn activity data into pipeline visibility for you and your investors, not just your reps.

Lead Scoring & Routing Logic

Scoring models and routing rules that get the right lead to the right rep before it goes cold.

Tooling Stack Selection

We choose and configure the CRM, enrichment, and outbound tools that fit your stage, not the ones that fit an agency’s retainer.

Handoff Docs & Training

Playbooks and recorded training so your team owns the system the day we hand it back.

Clinical & Network Access

Advisory councils, clinician networks and conference-driven signal intelligence, so you reach provider, payer and pharma buyers through credibility rather than volume.

FAQ

How long are healthcare sales cycles and can you shorten them?

Nine to eighteen months is normal for provider and payer deals. The lever is not speed of outreach, it is getting into the room before the requirements are written, because buyers commit early and rarely revisit.

Do you have real healthcare experience or is this a generalist team?

The division is led by Kori Bivens, a former VP at RVO Health with over ten years in healthcare. Vertical fluency is the product, not a positioning line.

Who do you sell to: providers, payers or pharma?

All three, and we help you work out which is actually your core ICP if that is still open. Healthcare is not one market and the segment economics differ.

Do you work with companies that are pre-FDA or pre-approval?

Generally no. If regulatory approval has to land before you can be commercial, we are early. The fit is founders ready to accelerate commercialization now.

How do you reach healthcare buyers that generic outbound cannot?

Through networks and credibility rather than volume: advisory councils, clinician networks, and conference-driven signal intelligence with a follow-through system behind it.

Let’s look at your go-to-market.

The fastest way to see how we think is a growth audit of your current GTM, no pitch, just where the leverage is.

Book Time